Skip to main content
NCBI home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1983 Oct;59(5):320–324. doi: 10.1136/sti.59.5.320

Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole.

M V Fast, H Nsanze, F A Plummer, L J D'Costa, I W MacLean, A R Ronald
PMCID: PMC1046218  PMID: 6351957

Abstract

Since sulphonamides are no longer predictably effective in the treatment of chancroid the combination of trimethoprim-sulphamethoxazole (TMP-SMX) was evaluated to identify other effective regimens. One hundred and nine patients with genital ulcers (75 men and 34 women) seen at the Special Treatment Clinic in Nairobi, Kenya, were randomly assigned to treatment with a seven day course of either sulphamethoxazole 1000 mg twice daily or trimethoprim (160 mg)-sulphamethoxazole (800 mg) (TMP-SMX) twice daily. Haemophilus ducreyi was isolated from the ulcer in 57 patients (33 men and 24 women). 16 patients were subsequently diagnosed serologically as having syphilis. No aetiological diagnosis was made in 40 patients. Treatment with sulphamethoxazole failed in five of 21 (24%) culture positive patients who were available for evaluation after seven days, whereas all 19 of such patients who were treated with TMP-SMX responded to treatment. Of the 21 isolates available for susceptibility testing, all were susceptible to trimethoprim alone (MIC less than 0.5 mg/l) and three were resistant to sulphonamides, all three containing a 4.9 megadalton (Mdal) plasmid. Two of the three patients from whom these isolates had been obtained were treated with sulphamethoxazole and both were clinical and bacteriological failures. Five of six patients with sulphonamide-susceptible H ducreyi responded to treatment with sulphamethoxazole. Failure of sulphonamides to eradicate H ducreyi in some patients with chancroid is associated with the presence of a sulphonamide resistant plasmid. In regions where this plasmid is present in H ducreyi TMP-SMX is the preferred treatment for chancroid.

Full text

PDF
320

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASIN J. Chancroid; a report of 1,402 cases. Am J Syph Gonorrhea Vener Dis. 1952 Sep;36(5):483–487. [PubMed] [Google Scholar]
  2. Fast M. V., Nsanze H., D'Costa L. J., Karasira P., Maclean I. W., Piot P., Albritton W. L., Ronald A. R. Antimicrobial therapy of chancroid: an evaluation of five treatment regimens correlated with in vitro sensitivity. Sex Transm Dis. 1983 Jan-Mar;10(1):1–6. [PubMed] [Google Scholar]
  3. Hammond G. W., Lian C. J., Wilt J. C., Albritton W. L., Ronald A. R. Determination of the hemin requirement of Haemophilus ducreyi: evaluation of the porphyrin test and media used in the satellite growth test. J Clin Microbiol. 1978 Mar;7(3):243–246. doi: 10.1128/jcm.7.3.243-246.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother. 1978 Apr;13(4):608–612. doi: 10.1128/aac.13.4.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hammond G. W., Slutchuk M., Lian C. J., Wilt J. C., Ronald A. R. The treatment of chancroid: comparison of one week of sulfisoxazole with single dose doxycycline. J Antimicrob Chemother. 1979 May;5(3):261–265. doi: 10.1093/jac/5.3.261. [DOI] [PubMed] [Google Scholar]
  6. Kerber R. E., Rowe C. E., Gilbert K. R. Treatment of chancroid. A comparison of tetracycline and sulfisoxazole. Arch Dermatol. 1969 Nov;100(5):604–607. [PubMed] [Google Scholar]
  7. Lüders G., Braun J., Pietzcker F., Schüle D. Neue therapeutische Gesichtspunkte beim Ulcus molle. Hautarzt. 1975 Jan;26(1):35–40. [PubMed] [Google Scholar]
  8. Marmar J. L. The management of resistant chancroid in Vietnam. J Urol. 1972 May;107(5):807–808. doi: 10.1016/s0022-5347(17)61144-3. [DOI] [PubMed] [Google Scholar]
  9. Nayyar K. C., Stolz E., Michel M. F. Rising incidence of chancroid in Rotterdam. Epidemiological, clinical, diagnostic, and therapeutic aspects. Br J Vener Dis. 1979 Dec;55(6):439–441. doi: 10.1136/sti.55.6.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nsanze H., Fast M. V., D'Costa L. J., Tukei P., Curran J., Ronald A. Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis. 1981 Dec;57(6):378–381. doi: 10.1136/sti.57.6.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stamps T. J. Experience with doxycycline (Vibramycin) in the treatment of chancroid. J Trop Med Hyg. 1974 Mar;77(3):55–60. [PubMed] [Google Scholar]
  12. Storey G. Clinical manifestations of chancroid. Br J Urol. 1970 Dec;42(6):738–738. [PubMed] [Google Scholar]
  13. WILLCOX R. R. The treatment of chancroid. Br J Clin Pract. 1963 Aug 8;17:455–460. [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES